| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |